Parnell Pharmaceuticals Holdings, a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing animal health solutions, has formed a contract manufacturing agreement with Merial, the animal health division of Sanofi. Merial will purchase certain sterile injectable products, exclusively from Parnell, with minimum annual purchase commitments over the 10-year term of the agreement.  In addition, Merial will pay an upfront establishment fee in ret...